Telix Pharmaceuticals: Merger Bodes Well For Long-Term Plan

A decade ago, tech companies were seen as climate leaders, moving faster than the rest of corporate America in the transition to clean energy. Now, as soaring data center demand pushes them toward greater use of fossil fuels, these same companies are increasingly cast as climate villains. One analysis of 60 of the largest planned…

Top 25 Firm Eide Bailly will acquire accounting and advisory firm MUN, effective Aug. 17. Processing Content MUN services clients across healthcare, real estate, nonprofits, employee benefit plans, local governments, manufacturing and hospitality. The deal adds offices in Glendale, California; Roseville, California; Lihue, Hawaii; Zephyr Cove, Nevada; and a second office in Sacramento. Jeremy Hauk…

Joseph Sohm / Shutterstock.com Commitment to Our Readers GOBankingRates’ editorial team is committed to bringing you unbiased reviews and information. We use data-driven methodologies to evaluate financial products and services – our reviews and ratings are not influenced by advertisers. You can read more about our editorial guidelines and our products and services review methodology….

Investors choosing between Arm Holdings (ARM +4.04%) and ASML Holding N.V. (ASML +3.08%) face a classic dilemma: do you buy the architect of mobile computing or the gatekeeper of advanced chip manufacturing? Arm licenses its energy-efficient architecture to nearly every chipmaker, while ASML builds the massive machines that print those designs onto silicon. Both companies…

Argenx (ARGX +0.83%) already markets Vyvgart Hytrulo for treating generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), two rare chronic autoimmune diseases. It appears to be on track to add another approved indication for the drug. On Aug. 17, 2026, Argenx announced positive results from a Phase 3 clinical study evaluating Vyvgart Hytrulo…